Venture Visionary Partners LLC Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Venture Visionary Partners LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 214.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,979 shares of the medical equipment provider’s stock after buying an additional 2,032 shares during the period. Venture Visionary Partners LLC’s holdings in Intuitive Surgical were worth $1,070,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Baker Tilly Wealth Management LLC raised its holdings in Intuitive Surgical by 253.3% during the fourth quarter. Baker Tilly Wealth Management LLC now owns 8,925 shares of the medical equipment provider’s stock worth $3,207,000 after purchasing an additional 6,399 shares in the last quarter. Parcion Private Wealth LLC raised its holdings in Intuitive Surgical by 3.4% during the fourth quarter. Parcion Private Wealth LLC now owns 1,109 shares of the medical equipment provider’s stock worth $344,000 after purchasing an additional 36 shares in the last quarter. Guyasuta Investment Advisors Inc. raised its holdings in Intuitive Surgical by 200.0% during the fourth quarter. Guyasuta Investment Advisors Inc. now owns 948 shares of the medical equipment provider’s stock worth $341,000 after purchasing an additional 632 shares in the last quarter. Teachers Retirement System of The State of Kentucky raised its holdings in Intuitive Surgical by 193.6% during the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 26,278 shares of the medical equipment provider’s stock worth $9,442,000 after purchasing an additional 17,328 shares in the last quarter. Finally, Arnhold LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $216,000. 44.03% of the stock is owned by institutional investors and hedge funds.

NASDAQ ISRG traded down $1.26 during mid-day trading on Thursday, reaching $243.26. 3,147,106 shares of the stock were exchanged, compared to its average volume of 2,181,277. Intuitive Surgical, Inc. has a 1-year low of $235.07 and a 1-year high of $369.69. The business’s fifty day simple moving average is $283.99 and its 200 day simple moving average is $312.87. The stock has a market capitalization of $87.32 billion, a PE ratio of 52.34, a PEG ratio of 7.15 and a beta of 1.17.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last announced its earnings results on Thursday, April 21st. The medical equipment provider reported $1.13 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.05. Intuitive Surgical had a net margin of 27.84% and a return on equity of 14.38%. The firm had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the business earned $1.17 earnings per share. Intuitive Surgical’s revenue was up 15.1% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical, Inc. will post 4.12 EPS for the current fiscal year.

Several research analysts recently issued reports on the stock. Truist Financial started coverage on shares of Intuitive Surgical in a report on Tuesday, April 12th. They set a “buy” rating and a $360.00 price target for the company. Raymond James lowered their target price on shares of Intuitive Surgical from $334.00 to $330.00 and set an “outperform” rating on the stock in a research report on Friday, April 22nd. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Intuitive Surgical from $323.00 to $300.00 and set a “hold” rating on the stock in a research report on Friday, January 21st. Redburn Partners lowered shares of Intuitive Surgical from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 25th. Finally, BTIG Research lowered their target price on shares of Intuitive Surgical from $372.00 to $360.00 and set a “buy” rating on the stock in a research report on Friday, January 21st. Eight research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $326.60.

In other Intuitive Surgical news, EVP Myriam Curet sold 2,478 shares of the stock in a transaction that occurred on Wednesday, February 16th. The shares were sold at an average price of $289.00, for a total transaction of $716,142.00. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile (Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.